IFNAR1 and Zika virus infectious disease: To investigate if the adjuvants increased protection against ZIKV infection, immunized mice were challenged with a high-dose ZIKV (strain R103451, 6 × 105 PFU/mouse) one day after administering an anti-Ifnar1 antibody (Figure 1).